GPGrissana Pook-In

Grissana Pook-In

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Grissana Pook-In has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anti-Inflammatory Effects of Artocarpin-Loaded Chitosan Microparticles on Inflammatory Chondrocytes

    by Piyapan Manklinniam, Ratsada Praphasawat, Arthid Thim-Uam, Grissana Pook-In, Jarupa Viyoch, Atchariya Yosboonruang

    Artocarpin is a promising bioactive compound with anti-inflammatory potential; however, its limited aqueous solubility may restrict its direct biological application. Therefore, artocarpin-loaded chitosan microparticles (CSPs/AE) were prepared as a biocompatible carrier to improve artocarpin delivery. This study aimed to evaluate the cytocompatibility, antioxidant activity, and anti-inflammatory effects of CSPs/AE in lipopolysaccharide (LPS)-stimulated chondrocytes. CSPs/AE maintained high cell viability (>80% at 0.125 and 0.5 mg/mL) and showed significantly lower cytotoxicity than free artocarpin. Morphological and DAPI analyses confirmed preserved cellular and nuclear integrity without marked apoptosis. CSPs/AE at 0.25 mg/mL reduced LPS-induced intracellular ROS accumulation by approximately 79% relative to the LPS group. Western blot results demonstrated inhibition of LPS-induced NF-κB phosphorylation, with CSPs/AE at 0.5 mg/mL reducing p-NF-κB expression to approximately 0.66-fold of that observed in the LPS group. CSPs/AE also partially restored aggrecan and collagen II expression without promoting a fibrocartilage, as indicated by unchanged collagen I. These findings indicate that CSPs/AE attenuate oxidative stress and inflammatory signaling while preserving cartilage matrix components, highlighting their potential for cartilage-protective applications.

  • Open Access

    Phytochemical Profiling, Antioxidant and Antibacterial Activities of Persicaria odorata Ethanolic Leaf Extract and Evaluation of Growth Performance, Disease Resistance, and Gene Expression in Labeo chrysophekadion (Bleeker, 1849)

    by Sontaya Sookying, Dutrudi Panprommin, Grissana Pook-In, Pinhatai Pardubyew, Thanatip Kaeothep, Tunyatorn Nakwong, Paiboon Panase

    Persicaria odorata is a medicinal plant recognized for its diverse biological activities. This study investigated the phytochemical profile, antioxidant and antibacterial activities of P. odorata ethanolic leaf extract (POE), as well as its effects on growth performance, disease resistance, and gene expression in Labeo chrysophekadion (Bleeker, 1849) over 150 days. Qualitative screening of POE confirmed the presence of phenolics and flavonoids associated with antioxidant and antibacterial properties. Quantitative analysis determined total phenolic and flavonoid contents in POE, and HPLC confirmed the presence of quercetin and catechin. The extract exhibited notable antioxidant capacity and antibacterial activity against selected pathogens. Dietary supplementation with POE at different inclusion levels resulted in numerically higher growth indices than the control, although differences were not statistically significant (p > 0.05). Fish fed 0.50 and 0.75 g/kg POE showed reduced cumulative mortality compared with the control and 0.25 g/kg group (p < 0.05). POE supplementation also upregulated IL-1β and IGF-1 expression, suggesting enhanced immune responses and growth regulation. Overall, POE shows potential as a natural feed additive to support fish health and disease resistance in aquaculture.


  • Open Access

    Microwave-Assisted Biosynthesis of Silver Nanoparticles Using Chlorella sp. for Antibacterial and Cytotoxicity Effects of Breast Cancer Cell Line

    by Piyapan Manklinniam, Weerawat Pornroongruengchok, Saranya Phunpruch, Adisorn Phaepilin, Grissana Pook-In, Atchariya Yosboonruang, Sarinrat Wonglee, Piyanud Thongjerm, Worakrit Worananthakij

    Microwave-assisted biosynthesis using marine Chlorella sp. extracts provides a green and efficient route for the production of silver nanoparticles (AgNPs). Compared with the conventional method (24 h), microwave-assisted synthesis reduces the reaction time to less than 7 min while producing smaller and more uniformly distributed nanoparticles. AgNPs were synthesized using extracts obtained with different solvents and directly compared with those produced via the conventional method to substantiate the efficiency of the microwave-assisted approach. UV–visible spectroscopy confirmed rapid nanoparticle formation, exhibiting surface plasmon resonance peaks in the range of 405 to 427 nm. TEM analysis revealed predominantly spherical AgNPs with particle sizes of approximately 10 to 20 nm. The XRD and FTIR analyses confirmed their crystalline structure and stabilization by algal-derived functional groups. The biological activities of the AgNPs were dependent on the extraction solvent. AgNPs synthesized using hexane extracts exhibited pronounced antibacterial activity, achieving minimum inhibitory concentrations as low as 0.31 µg/mL. In addition, the AgNP induced concentration-dependent cytotoxic effects in human breast cancer cell lines. IC50 values, determined via dose–response analysis, ranged from 0.18 to 0.67 μg/mL in MDA-MB-231 cells and 1.70 to 8.42 μg/mL in MCF-7 cells. These results indicate a potent cytotoxic profile, with MDA-MB-231 cells exhibiting significantly higher sensitivity to the microwave-assisted formulations. Collectively, these findings highlight microwave-assisted algal-mediated biosynthesis as a sustainable and effective platform for generating bioactive AgNPs with promising antibacterial and anticancer potential.


  • Open Access

    Heat-Assisted Extraction and Bioactivity Evaluation of a Dinactin-Associated Compound from Streptomyces UP Strains

    by Grissana Pook-In, Somsak Tammawong, Chorpaka Phuangsri, Khwanla Seansupa, Sontaya Sookying, Tomoko Takahashi, Anchalee Rawangkan

    Streptomyces is a versatile genus widely used in drug production and biotechnological applications. This study aimed to identify and characterize bioactive compounds produced by Streptomyces UP-AC4 and UP-3.2 strains and evaluate their antibacterial and anticancer activities. The strains were identified as Streptomyces californicus and Streptomyces purpurascens via chemotaxonomy, 16S rRNA sequencing, amplified ribosomal DNA restriction analysis, and phylogenetic analysis. Bioactive compounds were extracted using heat treatments at 63 °C for 30 min or 73–110 °C for 10 min. Antibacterial activity against Staphylococcus aureus, Bacillus cereus, and Escherichia coli was assessed by agar disc assay, with MICs of 0.024–0.195 mg/mL and MBCs of 0.098–0.391 mg/mL for the most effective extracts. Anticancer activity against A549, H1299, and Lu99 lung cancer cells was evaluated using the MTT assay, showing IC50 values of 0.23 ± 0.06 to 4.85 ± 0.64 mg/mL, while exhibiting no toxicity to normal fibroblast cells. HPLC analysis indicated that heat-assisted extraction of UP-AC4 at 73 °C for 10 min enriched a dinactin-associated compound as a predominant metabolite with antibiotic and anticancer activities. In conclusion, Streptomyces UP-AC4 and UP-3.2 produce promising low-cost bioactive compounds with strong potential for pharmaceutical and healthcare applications.


  • Open Access

    Restoring Multidrug-Resistant Escherichia coli Sensitivity to Ampicillin in Combination with (−)-Epigallocatechin Gallate

    by Anong Kiddee, Atchariya Yosboonruang, Achiraya Siriphap, Grissana Pook-In, Chittakun Suwancharoen, Acharaporn Duangjai, Ratsada Praphasawat, Masami Suganuma, Anchalee Rawangkan

    Multidrug-resistant (MDR) bacteria, especially Escherichia coli, are a major contributor to healthcare-associated infections globally, posing significant treatment challenges. This study explores the efficacy of (−)-epigallocatechin gallate (EGCG), a natural constituent of green tea, in combination with ampicillin (AMP) to restore the effectiveness of AMP against 40 isolated MDR E. coli strains. Antimicrobial activity assays were conducted to determine the minimum inhibitory concentrations (MIC) of EGCG using the standard microdilution technique. Checkerboard assays were employed to assess the potential synergistic effects of EGCG combined with AMP. The pharmacodynamic effects of the combination were evaluated through time-kill assays. Outer membrane disruption was analyzed by measuring DNA and protein leakage and with assessments using N-phenyl-1-naphthylamine (NPN) and rhodamine 123 (Rh123) fluorescence dyes. Biofilm eradication studies involved biofilm formation assays and preformed biofilm biomass and viability assays. Scanning electron microscopy (SEM) was used to examine changes in cellular morphology. The results indicated that EGCG demonstrated activity against all isolates, with MICs ranging from 0.5 to 2 mg/mL, while AMP exhibited MIC values between 1.25 and 50 mg/mL. Importantly, the EGCG-AMP combination showed enhanced efficacy compared to either treatment alone, as indicated by a fractional inhibitory concentration index between 0.009 and 0.018. The most pronounced synergy was observed in 13 drug-resistant strains, where the MIC for EGCG dropped to 8 µg/mL (from 1 mg/mL alone) and that for AMP to 50 µg/mL (from 50 mg/mL alone), achieving a 125-fold and 1000-fold reduction, respectively. Time-kill assays revealed that the bactericidal effect of the EGCG-AMP combination occurred within 2 h. The mechanism of EGCG action includes the disruption of membrane permeability and biofilm eradication in a dose-dependent manner. SEM confirmed that the combination treatment consistently outperformed the individual treatments. This study underscores the potential of restoring AMP efficacy in combination with EGCG as a promising strategy for treating MDR E. coli infections.